Exact Sciences Corp.
EXAS
Market Cap$10.12B
Close$
$-38.68
172.8% downside
Current Fair Value
172.8% downsideOvervalued by 172.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.12 Billion |
|---|---|
| Enterprise Value | $12.29 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.59 |
| Beta | 0.98 |
| Outstanding Shares | 186,813,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.83 |
|---|---|
| PEG | 120.19 |
| Price to Sales | 3.54 |
| Price to Book Ratio | 4.43 |
| Enterprise Value to Revenue | 4.35 |
| Enterprise Value to EBIT | -11.68 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 1.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Exact Sciences Corp.
CEO: Kevin Conroy